Enhanced antitumor effects by chemical modified IGb3 analogues.
Zhou Z, Zhang C, Xia C, Chen W, Zhu H, Shang P, Ma F, Wang PG, Zhang J, Xu W, Tian Z.
Zhou Z, et al.
Mol Cancer Ther. 2011 Aug;10(8):1375-84. doi: 10.1158/1535-7163.MCT-11-0030. Epub 2011 Jun 8.
Mol Cancer Ther. 2011.
PMID: 21653685